These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25069266)

  • 21. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.
    Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F
    Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms.
    Kim J; Yoon H; Basak J; Kim J
    Mol Cells; 2014 Nov; 37(11):767-76. PubMed ID: 25358504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.
    Zhao N; Liu CC; Qiao W; Bu G
    Biol Psychiatry; 2018 Feb; 83(4):347-357. PubMed ID: 28434655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery.
    Song Q; Song H; Xu J; Huang J; Hu M; Gu X; Chen J; Zheng G; Chen H; Gao X
    Mol Pharm; 2016 Nov; 13(11):3976-3987. PubMed ID: 27700119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease: the cholesterol connection.
    Puglielli L; Tanzi RE; Kovacs DM
    Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies.
    Raulin AC; Doss SV; Trottier ZA; Ikezu TC; Bu G; Liu CC
    Mol Neurodegener; 2022 Nov; 17(1):72. PubMed ID: 36348357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
    Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
    Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ApoE: crossroads between Alzheimer's disease and atherosclerosis.
    Stojakovic T; Scharnagl H; März W
    Semin Vasc Med; 2004 Aug; 4(3):279-85. PubMed ID: 15630629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?
    Kanekiyo T; Xu H; Bu G
    Neuron; 2014 Feb; 81(4):740-54. PubMed ID: 24559670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death.
    Bruinsma IB; Wilhelmus MM; Kox M; Veerhuis R; de Waal RM; Verbeek MM
    Brain Res; 2010 Feb; 1315():169-80. PubMed ID: 20034483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation and function of apolipoprotein E-containing lipoproteins in the nervous system.
    Vance JE; Hayashi H
    Biochim Biophys Acta; 2010 Aug; 1801(8):806-18. PubMed ID: 20170744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels.
    Lee CY; Tse W; Smith JD; Landreth GE
    J Biol Chem; 2012 Jan; 287(3):2032-44. PubMed ID: 22130662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of cholesterol in amyloid cascade: cholesterol-dependent modulation of tau phosphorylation and mitochondrial function.
    Michikawa M
    Acta Neurol Scand Suppl; 2006; 185():21-6. PubMed ID: 16866907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease.
    Zlokovic BV
    JAMA Neurol; 2013 Apr; 70(4):440-4. PubMed ID: 23400708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis.
    Chen Y; Strickland MR; Soranno A; Holtzman DM
    Neuron; 2021 Jan; 109(2):205-221. PubMed ID: 33176118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of apolipoprotein E inhibits the oligomer growth of amyloid-β peptide in solution as determined by fluorescence cross-correlation spectroscopy.
    Ly S; Altman R; Petrlova J; Lin Y; Hilt S; Huser T; Laurence TA; Voss JC
    J Biol Chem; 2013 Apr; 288(17):11628-35. PubMed ID: 23430745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier.
    Chernick D; Ortiz-Valle S; Jeong A; Qu W; Li L
    Neurosci Lett; 2019 Aug; 708():134306. PubMed ID: 31181302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesterol and apolipoprotein E in Alzheimer's disease.
    Reiss AB
    Am J Alzheimers Dis Other Demen; 2005; 20(2):91-6. PubMed ID: 15844755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.